 |
 |
GE chief Culp sells biopharma business for $21 billion |
 |
Shares of General Electric Co surged 11 percent on Monday after the U.S. industrial conglomerate said it would sell its biopharma business to Danaher Corp for $21 billion, its first major asset sale under new Chief Executive Officer Larry Culp. |
|
 |
 |
 |
Bayer faces second trial over alleged Roundup cancer risk |
 |
Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court. |
|
 |
|
 |
 |
 |
 |
Related Video |
|
 |
|
 |
|
 |
 |
 |
 |
 |
Make sense of the market with highlights of valuable financial information and reports along with compelling investment insights. Register Today |
 |
|
 |
 |
 |
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today |
 |
|
 |
» » MORE NEWSLETTERS |
 |
|